Liver diseases are a major health concern and affect a large proportion of people worldwide. There are over 100 types of liver disorders, including cirrhosis, cholangiocarcinoma (CCA), hepatocellular carcinoma, and hepatitis. Despite the relevant number of people who are affected by liver diseases, and the increased awareness with regard to these disorders, the number of deaths corresponding to liver injury is expected to increase in the foreseeable future. One of the possible reasons for this is that a complete comprehension of the mechanisms of hepatic damage involving specific liver anatomical districts is lacking, and, as a consequence, current treatments available are suboptimal.

Functional role of the secretin/secretin receptor signaling during cholestatic liver injury / Wu, N.; Baiocchi, L.; Zhou, T.; Kennedy, L.; Ceci, L.; Meng, F.; Sato, K.; Wu, C.; Ekser, B.; Kyritsi, K.; Kundu, D.; Chen, L.; Meadows, V.; Franchitto, A.; Alvaro, D.; Onori, P.; Gaudio, E.; Lenci, I.; Francis, H.; Glaser, S.; Alpini, G.. - In: HEPATOLOGY. - ISSN 0270-9139. - 72:6(2020), pp. 2219-2227. [10.1002/hep.31484]

Functional role of the secretin/secretin receptor signaling during cholestatic liver injury

Ceci L.;Franchitto A.;Alvaro D.;Onori P.;Gaudio E.;
2020

Abstract

Liver diseases are a major health concern and affect a large proportion of people worldwide. There are over 100 types of liver disorders, including cirrhosis, cholangiocarcinoma (CCA), hepatocellular carcinoma, and hepatitis. Despite the relevant number of people who are affected by liver diseases, and the increased awareness with regard to these disorders, the number of deaths corresponding to liver injury is expected to increase in the foreseeable future. One of the possible reasons for this is that a complete comprehension of the mechanisms of hepatic damage involving specific liver anatomical districts is lacking, and, as a consequence, current treatments available are suboptimal.
2020
CCA; cholangiocarcinoma; CFTR; cystic fibrosis transmembrane conductance regulator; dnTGF-βRII; dominant-negative transforming growth factor β receptor II; Mdr2; multidrug resistance 2 (Abcb4); miRNA; microRNA; NGF; nerve growth factor; PBC; primary biliary cholangitis; PKA; protein kinase A; PSC; primary sclerosing cholangitis; Sct; secretin0
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Functional role of the secretin/secretin receptor signaling during cholestatic liver injury / Wu, N.; Baiocchi, L.; Zhou, T.; Kennedy, L.; Ceci, L.; Meng, F.; Sato, K.; Wu, C.; Ekser, B.; Kyritsi, K.; Kundu, D.; Chen, L.; Meadows, V.; Franchitto, A.; Alvaro, D.; Onori, P.; Gaudio, E.; Lenci, I.; Francis, H.; Glaser, S.; Alpini, G.. - In: HEPATOLOGY. - ISSN 0270-9139. - 72:6(2020), pp. 2219-2227. [10.1002/hep.31484]
File allegati a questo prodotto
File Dimensione Formato  
Wu_Fuctional-role_2020.pdf

Open Access dal 24/12/2021

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 247 kB
Formato Adobe PDF
247 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1469736
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 15
social impact